Replies to post #806549 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

No, I am not mistaken on what is in the company evidence submission to NICE or what the timeline is. It is mostly about QALY and generally is well prior to the MHRA action and the commiitee can meet (in private) and discuss prior to MHRA approval.

See my example of Donenamabe I gave biosec.

Company evidence submission (starts P4). Dated March 19, 2024
Committee slides dated July 3, 2024

Both of these have plenty of discussion of QALY. And well prior to the MHRA approval in Oct 2024.

As another example, see Casegevy. Company evidence submission July 9, 2023
Plenty of discussion of QALY well prior to MHRA approval in Nov 2023.